Yael Glassman

Yael Glassman has extensive experience in the healthcare and technology sectors, particularly in diabetes care and digital health. As Vice President of Business Development and Strategy for Diabetes at Medtronic from January 2019 to April 2021, Yael led global partnerships and strategic investments to foster innovation and growth. Prior to that, as CEO and President of Nutrino Health, Yael spearheaded the company’s strategy and partnerships, resulting in a successful acquisition by Medtronic. Earlier roles include Vice President of Business Development at Sensible Medical Innovations Ltd. and Vice President of Marketing at Amwell, where Yael was instrumental in the launch and growth of telehealth services. Yael holds an MBA from the MIT Sloan School of Management and a BA in Psychology from The Hebrew University of Jerusalem.